China Universal Asset Management Company’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.9K | Buy |
5,447
+14
| +0.3% | +$182 | 0.01% | 391 |
|
|
2025
Q1 | $57.5K | Sell |
5,433
-311
| -5% | -$3.29K | 0.01% | 407 |
|
|
2024
Q4 | $97.5K | Buy |
5,744
+543
| +10% | +$9.22K | 0.01% | 394 |
|
|
2024
Q3 | $121K | Buy |
5,201
+2,038
| +64% | +$47.3K | 0.01% | 342 |
|
|
2024
Q2 | $77K | Sell |
3,163
-1,990
| -39% | -$48.5K | 0.01% | 317 |
|
|
2024
Q1 | $174K | Buy |
5,153
+2,064
| +67% | +$69.7K | 0.02% | 308 |
|
|
2023
Q4 | $97.4K | Buy |
3,089
+2,406
| +352% | +$75.9K | 0.02% | 283 |
|
|
2023
Q3 | $17.5K | Buy |
683
+335
| +96% | +$8.56K | 0.01% | 306 |
|
|
2023
Q2 | $9.98K | Sell |
348
-12
| -3% | -$344 | ﹤0.01% | 318 |
|
|
2023
Q1 | $8.63K | Buy |
360
+91
| +34% | +$2.18K | ﹤0.01% | 311 |
|
|
2022
Q4 | $4.56K | Buy |
269
+20
| +8% | +$339 | ﹤0.01% | 309 |
|
|
2022
Q3 | $4K | Buy |
+249
| New | +$4K | ﹤0.01% | 288 |
|